site stats

Giant biogene holding co ltd

WebNov 5, 2024 · Giant Biogene Holding Co., Ltd is a leader in the bioactive ingredient-based professional skin treatment product industry in China. The company designs, develops …

2367.HK Giant Biogene Holding Co. Ltd. Financial Statements - WSJ

WebApr 12, 2024 · Giant Biogene Holding Co Ltd is a China-based investment holding company. The Company is principally engaged the research, development, manufacture and sale … WebCompany profile for Giant Biogene Holding Co. Ltd. including key executives, insider trading, ownership, revenue and average growth rates. View detailed 2367.HK description & address. finishing翻译 https://gbhunter.com

Giant Biogene Holding SZSC:2367 Stock Report - simplywall.st

WebGet Giant Biogene Holding Co Ltd (2367-HK:Hong Kong Stock Exchange) real-time stock quotes, news, price and financial information from CNBC. Skip Navigation watch live WebStock analysis for Giant Biogene Holding Co ltd (2367:Hong Kong) including stock price, stock chart, company news, key statistics, fundamentals and company profile. WebMar 29, 2024 · Jianya Yan. Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People’s Republic of China. It also manufactures rare ginsenosides technology-based functional foods; and offers medical … finish ing 意味

Giant Biogene Holding (2367) Analysts Prediction, Stock Forecast ...

Category:GIANT BIOGENE HOLDING CO., LTD. : Revenue and Earnings …

Tags:Giant biogene holding co ltd

Giant biogene holding co ltd

Giant Biogene Holding Co. Ltd. - MarketWatch

WebLearn more about Giant Biogene Holding Co., Ltd. (2367). From their employee growth over the years and their exchange listings. Home Markets Discover Watchlist Portfolios Screener. Giant Biogene Holding Co., Ltd. SZSC:2367 Stock Report. Mkt Cap: HK$46.5b. Add to watchlist. Company Overview; 1 Valuation; 2 Future Growth; WebGiant Biogene Holding Co., Ltd. (2367.HK) Stock Historical Prices & Data - Yahoo Finance Giant Biogene Holding Co., Ltd. (2367.HK) HKSE - HKSE Delayed Price. Currency in HKD Follow 46.600...

Giant biogene holding co ltd

Did you know?

WebOct 25, 2024 · China's Giant Biogene Holding Co Ltd launched on Tuesday an initial public offering (IPO) in Hong Kong to raise up to $80 million, a term sheet showed, … WebFind company research, competitor information, contact details & financial data for Giant Biogene Holding Co Ltd of Grand Cayman, GRAND CAYMAN. Get the latest business …

WebGiant Biogene Holding Co. Ltd. annual income statement. View 2367.HK financial statements in full, including balance sheets and ratios. Nikkei 26945.67 points with a 1.42% WebApr 3, 2024 · Future criteria checks 0/6. Giant Biogene Holding is forecasted to grow earnings and revenue by 32.7% and 29.9% per annum respectively. EPS and ROE are also expected to grow by 27.6% and 29.8% per year respectively. Analyst coverage for Giant Biogene Holding stock is good.

WebGiant Biogene Holding Co., Ltd. Revisions 2367 KYG3887G1091. GIANT BIOGENE HOLDING CO., LTD. (2367) Add to my list. Report. Delayed Hong Kong Stock Exchange - 04:08:31 2024-04-06 am EDT 47.65: HKD +0.11%: 03/28: Giant Biogene Logs 21% Jump in 2024 Profit : MT. 03/27: Giant Biogene Holding Co., Ltd. Reports Earnings Results … WebApr 11, 2024 · Company Profile 02367. Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the …

WebDiscover historical prices for 2367.HK stock on Yahoo Finance. View daily, weekly or monthly format back to when Giant Biogene Holding Co., Ltd. stock was issued.

WebMar 29, 2024 · Giant Biogene Holding Co Ltd is a China-based investment holding company. The Company is principally engaged the research, development, manufacture and sale of bioactive material-based beauty and health products through its s ubsidiaries. The Company's main products include functional skincare products and medical … finish in hindiWebGiant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. we also … finish in malayWebNews Giant Biogene Holding Co. Ltd. Significant News Only No significant news for 2367 in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) N/A Market Cap … esgp pa scholarship requirementsWebApr 11, 2024 · Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People’s Republic of China. About the company Rewards Earnings are forecast to grow 32.66% per year Revenue grew by 52.3% over the past … finish in other languagesWebGiant Biogene Holding Co. Ltd. Watch list Closed Last Updated: Feb 10, 2024 4:08 p.m. HKST Delayed quote HK$ 47.60 -2.55 -5.08% Advanced Charting $ % Vol Volume: 639.4K 65 Day Avg: 797.04K 80% vs... finish in past perfectWebApr 19, 2024 · Giant Biogene Holding Co Ltd HKSE :02367 (China) Portfolio HK$ 44.60 (-8.23%) Apr 12 Warning! GuruFocus detected 1 Severe warning sign with 02367. Try a 7-Day Free Trial to check it out. Volume: 1.35M Market Cap HK$: 44.38B Market Cap $: 5.65B PE Ratio: 43.69 Avg Vol (2M): 868.04K Enterprise Value HK$: 47.14B Enterprise Value … esg product manager bloombergWebGiant Biogene Holding Co Ltd is a China-based investment holding company. The Company is principally engaged the research, development, manufacture and sale of bioactive … esg priority